ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

September 25, 2009

Merger Of Centers, Control Programs An Option, Upton Says; ACS To Fund New Prevention Centers

February 2, 1979

Mammography Screening For Ages 40-49 Not Supported By Data, NIH Pane! Says

January 31, 1997

History: Breast Cancer Screening A 30-Year War Against “Confusion”

November 20, 2009

High-Dose Chemo Can Cure Rare Pediatric Brain Tumor

February 25, 2005

House Appropriations by Institute

July 8, 1994